Follow
Daniel Herrero Rivera
Daniel Herrero Rivera
Medical Oncologist, HLA Moncloa University Hospital
No verified email
Title
Cited by
Cited by
Year
Cardiovascular disease and survival in non-small cell lung cancer: a multicenter prospective assessment
D Herrero Rivera, JM Nieto-Guerrero Gómez, ...
Clinical and Translational Oncology 21, 1220-1230, 2019
222019
Association of single nucleotide polymorphisms at HSPB1 rs7459185 and TGFB1 rs11466353 with radiation esophagitis in lung cancer
BD Delgado, MV Enguix-Riego, JCF de Bobadilla, DH Rivera, ...
Radiotherapy and Oncology 135, 161-169, 2019
132019
Impact of pre-radiation therapy quality of life in lung cancer survival: a prospective, intention-to-treat, multicenter study
JM Nieto-Guerrero Gomez, GP Silva Vega, J Cacicedo, BD Delgado León, ...
Clinical and Translational Oncology 22, 1635-1644, 2020
82020
The single nucleotide variant rs2868371 associates with the risk of mortality in non-small cell lung cancer patients: a multicenter prospective validation
M del Valle Enguix-Riego, J Cacicedo, BDD León, JMNG Gómez, ...
Radiotherapy and Oncology 136, 29-36, 2019
82019
OC-0153: Multicenter prospective validation of HSPB1 rs2868371 SNP and survival in non-small cell lung cancer
M Enguix-Riego, JCF de Bobadilla, DH Rivera, D Delgado, JNG Gómez, ...
Radiotherapy and Oncology 127, S77, 2018
12018
Development and independent validation of a predictive gene expression signature based on RB1, PTEN, and TP53 in patients with metastatic hormone-sensitive metastatic prostate …
O Reig Torras, M Garcia de Herreros, N Jiménez, C Aversa, ...
Journal of Clinical Oncology 41 (16_suppl), 5083-5083, 2023
2023
Development and validation of a gene expression signature based on RB1, PTEN, and TP53 in patients with metastatic hormone-sensitive prostate cancer …
O Reig Torras, N Jiménez, M Garcia de Herreros, C Aversa, M Marin, ...
Journal of Clinical Oncology 41 (6_suppl), 236-236, 2023
2023
Valor pronóstico y predictivo de polimorfismos en genes relacionados con el metabolismo y el mecanismo de acción del cabazitaxel en pacientes con cáncer de próstata avanzado
D Herrero Rivera
2023
Single-nucleotide polymorphism associations with efficacy and toxicity in metastatic castration-resistant prostate cancer treated with cabazitaxel
D Herrero Rivera, CG Vacas, LM Kovandzic, JP Vázquez, LA Alonso, ...
Pharmacogenomics 23 (11), 627-638, 2022
2022
Estrogen receptor β and TMPRSS2-ERG expression association with clinical outcomes in metastatic hormone-sensitive prostate cancer.
C Aversa, N Jiménez, M Marin, L Ferrer-Mileo, O Reig, ...
Journal of Clinical Oncology 40 (16_suppl), 5077-5077, 2022
2022
Integración de productos Cundiboyacenses de consumo mínimo en Bogotá con técnicas de cocina Vanguardista, mediante cursos prácticos gastronómicos.
D Rivera, L Carvajal, J Gómez
Bogotá, 2021
2021
Single nucleotide polymorphisms (SNPs) as predictors of efficacy of cabazitaxel in patients with metastatic castration-resistant prostate cancer (mCRPC).
DH Rivera, I Duran, L Marcos Kovandzic, J Puente, B Mellado, E Grande, ...
Journal of Clinical Oncology 38 (15_suppl), e17582-e17582, 2020
2020
IMPACTO PSICOLOGÍA PANDEMIA COVID-19 ASISTENCIA
D Herrero, S López, D Manzano, L Esteban, AB Fiorini, V De la Cruz, ...
Situación 4, 3, 2020
2020
Pre-radiotherapy quality of live assessment predicts survival in lung cancer patients
JM Nieto-Guerrero Gomez, J Cacicedo Fernandez de Bobadilla, ...
Radiotherapy and Oncology 127, S750-S751, 2018
2018
EP-1367: Cardiovascular disease and survival in lung cancer: a multicenter prospective assessment
DH Rivera, JMNG Gómez, JCF De Bobadilla, DB Delgado, ASC Mejías, ...
Radiotherapy and Oncology 127, S746, 2018
2018
EVALUACIÓN DEL IMPACTO SOCIOSANITARIO Y EMOCIONAL PROVOCADO POR LA COVID-19 EN UNA COHORTE SEGOVIANA DE PACIENTES ONCOLÓGICOS TRAS LA SEGUNDA OLEADA PANDÉMICA
D Herrero, S López, D Manzano, B Esteban, L García, AB Fiorini, ...
V REUNIÓN INVESTIGACIÓN Y SALUD, 25, 0
The system can't perform the operation now. Try again later.
Articles 1–16